Package 69238-1731-2

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 69238-1731-2
Digits Only 6923817312
Product NDC 69238-1731
Product ID 69238-1731_c11900df-97bb-47f5-8a29-05fe1586d556
Description

473 mL in 1 BOTTLE (69238-1731-2)

Marketing

Marketing Status
Marketed Since 2020-01-17
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c11900df-97bb-47f5-8a29-05fe1586d556", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["9c3a5abf-e217-4292-a305-5afd12b99e95"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (69238-1731-2)", "package_ndc": "69238-1731-2", "marketing_start_date": "20200117"}], "brand_name": "Pyridostigmine Bromide", "product_id": "69238-1731_c11900df-97bb-47f5-8a29-05fe1586d556", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "69238-1731", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "ANDA212702", "marketing_category": "ANDA", "marketing_start_date": "20200117", "listing_expiration_date": "20261231"}